Some types of sickle cell disease cause severe illness, while others have a mild or unapparent course. Sickle cell disease is present from birth and inherited from genes you receive from your parents.

Sickle cell anemia refers to a group of genetic blood disorders that affect a person’s levels of hemoglobin, the protein in ...

Research commissioned by the NHS Race and Health Observatory found a number of inequalities in care, funding and research provided for people with sickle cell disorder in comparison with those with ...

Cristina Pina receives funding from Children's Cancer and Leukaemia Group via the Little Princess Trust and the National Centre for the Replacement, Reduction and Refinement of Animals in Research.

Because SCD can impair blood and oxygen delivery to any part of the body, it can cause a wide range of complications, including anemia, blood clots, and stroke. It can also damage organs, such as the ...

Sickle cell disease (SCD) is an inherited disorder that affects over 100,000 people in the United States, according to the Sickle Cell Disease Association of America, of that number, the Centers for ...

Sickle cell disease can cause various eye-related complications, including retinopathy. If untreated, sickle cell retinopathy can cause permanent vision loss. Treatments include laser therapy and eye ...

Patients who underwent hematopoietic cell transplantation for sickle cell disease saw high rates of survival without disease ...

Patients who underwent hematopoietic cell transplantation for sickle cell disease saw high rates of survival without disease symptoms and low rates of severe side effects or complications years after ...

Most people with sickle cell disease who undergo allogeneic hematopoietic cell transplantation achieve favorable long-term ...

21 year old Sebastien Beauzile celebrates his Lyfgenia infusion with his medical team. Four months later, his doctors consider him cured from sickle cell anemia. A 21 year old man in New York has been ...

The first study assessing the real-world commercial roll-out of gene therapies for sickle cell disease and beta thalassemia ...